Studying how vancomycin is handled in newborns
Treatments studied
Part of Infections clinical trials.
This study looks at how the antibiotic vancomycin moves through and acts in newborn babies. It may help doctors dose the medicine more safely and effectively for babies in intensive care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is a newborn in the Neonatal Intensive Care Unit (NICU)
- Your baby is receiving vancomycin for a medical reason
- Parents or legal guardians can give informed consent
- A signed consent form must be available
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
This study asks NICUs to reduce the use of the antibiotic vancomycin. It's for hospital units that are part of certain networks and agree to follow the study plan.
This trial studies a better way to monitor and adjust vancomycin (an antibiotic) dosing in very young infants. It may help your baby get the right dose while reducing the risk of under- or over-dosing.
This study tests a personalized dosing approach for the antibiotic vancomycin given to patients in the neurological ICU. It aims to find the right dose for each patient to improve treatment and reduce side effects.
This study looks at giving vancomycin continuously in the ICU or orthopedics for the first time, to see if the dosing is done correctly. If you’re an adult receiving this treatment, the trial may help improve how safely and accurately vancomycin is managed.
This trial tests a different way of giving vancomycin to children with sepsis to reduce the risk of kidney injury. It compares standard dosing to an approach that adjusts dose based on how the kidneys are working.
Hear when a new Neonatal Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.